Suchergebnisse - "Gulick, Roy M"

PubPharm (263)

31

Prioritizing clinical research studies during the COVID-19 pandemic : lessons from New York City

enthalten in: The Journal of clinical investigation | 2020

von Gulick, R. | Sobieszczyk, M. | Landry, D. | +1

32

COVID-19 in Hospitalized Adults With HIV

enthalten in: Open forum infectious diseases | 2020

von Stoeckle, K. | Johnston, C. | Jannat-Khah, D. | +6

33

Clinical Characteristics of Covid-19 in New York City

enthalten in: The New England journal of medicine | 2020

von Goyal, P. | Choi, J. | Pinheiro, L. | +18

34

Drug Costs : What Can Infectious Diseases Physicians Do?

enthalten in: The Journal of infectious diseases | 2020

von Kapadia, S. | Gulick, R.

CommentOn: J Infect Dis. 2020 Feb 18;221(5):690-696. - PMID 30887033

35

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease

enthalten in: PloS one | 2020

von Satlin, M. | Goyal, P. | Magleby, R. | +9

36

HIV treatment and prevention 2019 : current standards of care

enthalten in: Current opinion in HIV and AIDS | 2020

von Phanuphak, N. | Gulick, R.

37

ART in HIV-Positive Persons With Low Pretreatment Viremia : Results From the START Trial

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2019

von Sereti, I. | Gulick, R. | Krishnan, S. | +7

38

Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL : week 48 outcomes from ACTG 5353

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Nyaku, A. | Zheng, L. | Gulick, R. | +19

39

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy

enthalten in: Open forum infectious diseases | 2019

von Bhagwat, P. | Kapadia, S. | Ribaudo, H. | +2

40

Long-Acting HIV Drugs for Treatment and Prevention

enthalten in: Annual review of medicine | 2019

von Gulick, R. | Flexner, C.